Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Hay, Keeva
DOB: 29-FEB-1944 (Age: 81)
Gender: female
Address:
58 Layburn Court
SY17 0EJ Trefeglwys (United Kingdom)
ID: 5817-011848-1
Report
Date: 12-APR-2024
Laboratory
Requested by
Llanidloes War Memorial Hospital
Eastgate Street nan
SY18 6 Llanidloes (United Kingdom)
Specimen
Collected: 11-APR-2024

Chemistry

Test 11 Apr 2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4 - 6 %
Glucose [Mass/volume] in Blood 93.8 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 8.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.5 L 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.0 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 136.1 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.2 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.7 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.5 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c (6.2%) on two occasions, indicating suboptimal long-term glycemic control, suggestive of prediabetes or early diabetes. Renal function markers (urea, creatinine) are within or slightly below normal, likely not clinically significant in this context. Electrolytes, lipids, and other parameters are within normal limits. No acute abnormalities detected. Recommend monitoring glycemic control and clinical correlation.